Many of the most advanced scientific technologies in regenerative medicine involve animal or human embryonic stem cells.
Together with the scientific community, we believe that research using stem cells has the potential to help identify medicines, therapies and vaccines that will treat, cure or prevent diseases and alleviate the suffering of patients with significant unmet medical needs. Examples include Parkinson’s disease, cancer, cardiovascular disease, diabetes, osteoarthritis and trauma. We have been conducting research into the biology of stem cells for more than a decade. This research has involved the use of animal and human stem cells, as well as induced pluripotent stem cells.
We have been conducting research into the biology of stem cells for more than a decade.
We conduct research using stem cells in full accordance with all applicable laws and regulations and our own internal research policies. Our research policy involving stem cells is guided by the U.S. National Academy of Sciences as well as the International Society of Stem Cell Research guidelines. Our company’s Regenerative Medicine Oversight Committee, which comprises both internal and external experts, oversees company-sponsored research involving stem cells, including highly targeted research using human embryonic stem cells, stem cells developed through somatic cell nuclear transfer and induced pluripotent stem cells. The committee is responsible for ensuring that all projects involving stem cells adhere to our policies.